Depomed Sues Cadila, Zydus Over Generic Gralise
California-based Depomed brought suit after Cadila and Zydus Pharmaceuticals (USA) Inc. sought federal approval of an abbreviated new drug application to make and sell a generic version of Gralise before Depomed’s six patents had expired.
“Zydus has declared its intent to manufacture, use, offer to sell or sell...
Already a subscriber? Click here to login